by Action Matters | Jan 13, 2022 | Mass Torts, Zantac
Is Ranitidine Making a Comeback? 0 Comments Until the spring of 2020, Zantac and generic and store brand ranitidine-based drugs were widely used to treat gastrointestinal issues such as ulcers, heartburn, and gastroesophageal reflux disease (GERD). The drug was very...
by Action Matters | Oct 11, 2021 | Zantac
Generic Ranitidine Lawsuit Status 0 Comments In July, the federal MDL court dismissed all pending claims against generic and store-brand manufacturers of ranitidine. For people who took generic forms of ranitidine and have been diagnosed with cancer, or who lost...
by Action Matters | Sep 15, 2021 | Zantac
When Will the Zantac Cancer Cases Go to Trial? 0 Comments If you or a loved one has been diagnosed with cancer after taking Zantac, you’re probably wondering when juries will start hearing the thousands of lawsuits that are currently pending against manufacturers and...
